
Overview
KVP Team
Caley Castelein
Anupam Dalal
Andrew Jensen
Jim Shapiro
Dick Spalding
Venture Partners
David Bradford
Mike Chobotov
Richard Glickman
Senior Advisors
Victor Dzau
Don Ganem
Peter Hutt
Fred Moll
Thomas Weisel
|
Dr. Dzau is Chancellor for Health Affairs at Duke University
and President and CEO of the Duke University Health System
since July 2004. He is also James B. Duke Professor of
Medicine and Director of Molecular and Genomic Vascular
Biology at Duke. Prior to coming going to Duke, he served
as Hersey Professor of Medicine at Harvard Medical School
and Chairman of the Department of Medicine at Brigham
and Women's Hospital in Boston Massachusetts from 1996
to 2004. Prior to his work at Harvard and Brigham and
Women's, he served as Arthur Bloomfield Professor and
Chairman of the Department of Medicine at Stanford.
Dr. Dzau is a member of the Institute of Medicine of the
National Academy of Sciences and the European Academy
of Science and Arts. He was the previous Chairman of the
National Institutes of Health (NIH) Cardiovascular Disease
Advisory Committee and he served on the Advisory Committee
of the Director of NIH.
Dr. Dzau received the first Hatter Award from the Medical
Research Council of South Africa in 2000. He was awarded
the prestigious Gustav Nylin Medal by the Swedish Royal
College of Medicine and the Swedish Cardiology Society,
the Novartis Award for Hypertension Research by the American
Heart Association (which also named him one of its Distinguished
Scientists for 2004), the 2004 Max Delbruck Medal by the
Max Delbruck Center for Molecular Medicine, Berlin, Germany,
the 2005 Golden Door Award by the International Institute
of Boston, and a 2005 Ellis Island Medal of Honor by the
National Ethnic Coalition of Organizations.
Dr. Dzau is a Director at Pepsico Inc, Genzyme (Nasdaq:GENZ), Alnylam (Nasdaq: ALNY) and Medtronic (Nasdaq: MDT) and serves on the Scientific Advisory Board of CV Therapeutics (Nasdaq:CVTX), Atherogenics Inc. (Nasdaq:AGIX) and United Therapeutics (Nasdaq:UTHR).
Dr. Dzau received his M.D. from McGill University in Montreal
and underwent postgraduate training at the Brigham and
Women's Hospital in Boston.
|
|